PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 1, 20240 citationsOpen Access

Figure S26 from Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer

View Full Paper
MAMinae AnAMArnav MehtaBMByung‐Hoon Min

Key Points

Key points are not available for this paper at this time.

Abstract

Figure S26. (A) Proportion of CD8 T cells in non-responder and responder patients split by timepoint. Statistical comparisons performed using a Wilcoxon signed-rank test. (B) Multiplexed immunofluorescence (mIF) images of BL, FU1 and FU2 samples from two patients, E40 (slow progressor) and E41 (fast progressor), staining for panCK, PD-L1, CD4, CD8 and Granzyme B. (C) Proportion of CD8 T cells macrophages, obtained from mIF images, at BL, FU1 and FU2 in non-responder and responder patients. Statistical comparison performed using a Wilcoxon signed-rank test. (D) Proportion of naive, memory, effector and exhausted CD8 T cell subsets in non-responder and responder patients split by timepoint. Statistical comparisons performed using a Wilcoxon signed-rank test. (E) Proportion of regulatory T cell and Th1 CD4 T cell subsets in fast v.s. slow progressor patients split by timepoint. Statistical comparisons performed using a Wilcoxon signed-rank test. (F) Expression of CXCL13 in CD4 T cells in fast v.s. slow progressor patients split by timepoint. Statistical comparisons performed using a Wilcoxon signed-rank test.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

An et al. (2024) studied this question.

synapsesocial.com/papers/68e6c4bab6db643587643a58https://doi.org/10.1158/2159-8290.25728981.v1
Ask AI
Helpful
Bookmark
Share
View Full Paper